Pancreatic Cancer Research

ResearcherKyoto UniversityActive in the last 2 years

Kazuyuki Nagai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2180-2056; OpenAlex author ID A5022959950. Sources: OpenAlex.

Their work

Papers
14 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
62
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 3 papers · 2024: 1 paper · 2025: 4 papers · 2026: 3 papers

Papers 14

  1. Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Retrospective S… First author DOI 10.1097/sla.0000000000007052↗
  2. Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer. Co-author DOI 10.3390/cancers18071177↗
  3. Pancreatic Neuroendocrine Tumor with Acinar Pattern Mimicking Pancreatic Ductal Adenocarcinoma: A Case Report. Co-author DOI 10.70352/scrj.cr.26-0184↗
  4. Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit From Resection Under Specific Conditions: … Co-author DOI 10.1002/jhbp.12181↗
  5. Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resectable pancreatic cancer : Outcomes and pro… Co-author DOI 10.1007/s00066-025-02433-9↗
  6. Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatment benefits. Co-author DOI 10.1016/j.pan.2025.04.012↗
  7. Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Ret… Co-author DOI 10.1245/s10434-025-16956-z↗
  8. Reduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer. Co-author DOI 10.1016/j.pan.2024.09.002↗
  9. Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity-modulated radiotherapy for resectable pancreatic cancer: A pros… First author DOI 10.1002/cam4.6470↗
  10. Association between patient's age and the utility of prognostic markers after pancreaticoduodenectomy for pancreatic cancer. Co-author DOI 10.1016/j.asjsur.2022.10.009↗
  11. Preoperative Endoscopic Minor Papilla Sphincterotomy for Pancreas Divisum in a Patient with Pancreatic Cancer Who Underwent Laparoscopic Distal Pancreatectomy. Co-author DOI 10.1245/s10434-023-13975-6↗
  12. Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase… First author DOI 10.1186/s12885-022-09244-6↗
  13. Left-posterior approach for artery-first en bloc resection in laparoscopic distal pancreatectomy for left-sided pancreatic cancer. Co-author DOI 10.1007/s00423-020-02021-8↗
  14. Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadjuvant chemoradiotherapy: A retrospective… Co-author DOI 10.1016/j.suronc.2020.10.010↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Etsuro Hatano · 11 shared papers, 2022–2026 · strength 2.10
  2. Toshihiko Masui · 10 shared papers, 2020–2026 · strength 1.67
  3. Akihisa Fukuda · 7 shared papers, 2022–2026 · strength 1.27
  4. Kei Yamane · 6 shared papers, 2023–2026 · strength 1.26
  5. Michio Yoshimura · 6 shared papers, 2020–2025 · strength 1.00
  6. Asahi Sato · 4 shared papers, 2022–2026 · strength 0.72
  7. Yuichiro Uchida · 4 shared papers, 2020–2026 · strength 0.63
  8. Takahiro Iwai · 3 shared papers, 2025 · strength 0.62
  9. Takashi Mizowaki · 4 shared papers, 2020–2025 · strength 0.59
  10. Masashi Kanai · 3 shared papers, 2022–2025 · strength 0.48
  11. Junichi Matsubara · 2 shared papers, 2025 · strength 0.41
  12. Hiroshi Seno · 2 shared papers, 2024–2026 · strength 0.38
  13. Kei Iimori · 2 shared papers, 2024–2026 · strength 0.38
  14. Shinji Üemoto · 3 shared papers, 2020–2023 · strength 0.38
  15. Kyoichi Takaori · 3 shared papers, 2020–2022 · strength 0.34
  16. Shintaro Yagi · 2 shared papers, 2020–2026 · strength 0.32
  17. Atsuko Kasajima · 1 shared paper, 2026 · strength 0.25
  18. Yasunori Shirakawa · 1 shared paper, 2026 · strength 0.25
  19. Shinya Okumura · 1 shared paper, 2026 · strength 0.25
  20. Günter Klöppel · 1 shared paper, 2026 · strength 0.25
  21. Ayaka Ogawa · 1 shared paper, 2025 · strength 0.21
  22. Ryo Ashida · 1 shared paper, 2025 · strength 0.21
  23. Kosuke Minaga · 1 shared paper, 2026 · strength 0.21
  24. Munenori Kawai · 1 shared paper, 2026 · strength 0.21
  25. Toshihiro Morita · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.